FRM
Fox Run Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,015
| Closed | -$80.3K | – | 945 |
|
|
2024
Q2 | $80.3K | Buy |
+10,015
| New | +$80.3K | 0.02% | 731 |
|
|
2024
Q1 | – | Sell |
-22,712
| Closed | -$185K | – | 924 |
|
|
2023
Q4 | $185K | Buy |
22,712
+6,633
| +41% | +$53.9K | 0.05% | 641 |
|
|
2023
Q3 | $73.2K | Buy |
+16,079
| New | +$73.2K | 0.02% | 646 |
|
|
2022
Q4 | – | Sell |
-17,419
| Closed | -$167K | – | 755 |
|
|
2022
Q3 | $167K | Buy |
+17,419
| New | +$167K | 0.07% | 506 |
|
|
2022
Q2 | – | Sell |
-17,380
| Closed | -$289K | – | 635 |
|
|
2022
Q1 | $289K | Buy |
17,380
+4,918
| +39% | +$81.8K | 0.16% | 285 |
|
|
2021
Q4 | $238K | Buy |
12,462
+427
| +4% | +$8.16K | 0.14% | 307 |
|
|
2021
Q3 | $297K | Buy |
+12,035
| New | +$297K | 0.19% | 233 |
|
|
2020
Q3 | – | Sell |
-7,670
| Closed | -$211K | – | 247 |
|
|
2020
Q2 | $211K | Buy |
+7,670
| New | +$211K | 0.28% | 199 |
|
|
2020
Q1 | – | Sell |
-11,878
| Closed | -$329K | – | 244 |
|
|
2019
Q4 | $329K | Buy |
+11,878
| New | +$329K | 0.26% | 151 |
|
|
2018
Q2 | – | Sell |
-13,713
| Closed | -$232K | – | 790 |
|
|
2018
Q1 | $232K | Buy |
+13,713
| New | +$232K | 0.06% | 582 |
|